Table of Contents Executive Summary 1 Industry Overview of Vaccine Conjugate 1.1 Definition of Vaccine Conjugate 1.2 Vaccine Conjugate Segment by Type 1.2.1 Global Vaccine Conjugate Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Monovalent 1.2.3 Multivalent 1.2.4 Others 1.3 Vaccine Conjugate Segment by Applications 1.3.1 Global Vaccine Conjugate Consumption Comparison by Applications (2014-2025) 1.3.2 Influenza 1.3.3 Meningococcal 1.3.4 Pneumococcal 1.3.5 Others 1.4 Global Vaccine Conjugate Overall Market 1.4.1 Global Vaccine Conjugate Revenue (2014-2025) 1.4.2 Global Vaccine Conjugate Production (2014-2025) 1.4.3 North America Vaccine Conjugate Status and Prospect (2014-2025) 1.4.4 Europe Vaccine Conjugate Status and Prospect (2014-2025) 1.4.5 China Vaccine Conjugate Status and Prospect (2014-2025) 1.4.6 Japan Vaccine Conjugate Status and Prospect (2014-2025) 1.4.7 Southeast Asia Vaccine Conjugate Status and Prospect (2014-2025) 1.4.8 India Vaccine Conjugate Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Vaccine Conjugate 2.3 Manufacturing Process Analysis of Vaccine Conjugate 2.4 Industry Chain Structure of Vaccine Conjugate 3 Development and Manufacturing Plants Analysis of Vaccine Conjugate 3.1 Capacity and Commercial Production Date 3.2 Global Vaccine Conjugate Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Vaccine Conjugate 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Vaccine Conjugate Production and Capacity Analysis 4.2 Vaccine Conjugate Revenue Analysis 4.3 Vaccine Conjugate Price Analysis 4.4 Market Concentration Degree 5 Vaccine Conjugate Regional Market Analysis 5.1 Vaccine Conjugate Production by Regions 5.1.1 Global Vaccine Conjugate Production by Regions 5.1.2 Global Vaccine Conjugate Revenue by Regions 5.2 Vaccine Conjugate Consumption by Regions 5.3 North America Vaccine Conjugate Market Analysis 5.3.1 North America Vaccine Conjugate Production 5.3.2 North America Vaccine Conjugate Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Vaccine Conjugate Import and Export 5.4 Europe Vaccine Conjugate Market Analysis 5.4.1 Europe Vaccine Conjugate Production 5.4.2 Europe Vaccine Conjugate Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Vaccine Conjugate Import and Export 5.5 China Vaccine Conjugate Market Analysis 5.5.1 China Vaccine Conjugate Production 5.5.2 China Vaccine Conjugate Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Vaccine Conjugate Import and Export 5.6 Japan Vaccine Conjugate Market Analysis 5.6.1 Japan Vaccine Conjugate Production 5.6.2 Japan Vaccine Conjugate Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Vaccine Conjugate Import and Export 5.7 Southeast Asia Vaccine Conjugate Market Analysis 5.7.1 Southeast Asia Vaccine Conjugate Production 5.7.2 Southeast Asia Vaccine Conjugate Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Vaccine Conjugate Import and Export 5.8 India Vaccine Conjugate Market Analysis 5.8.1 India Vaccine Conjugate Production 5.8.2 India Vaccine Conjugate Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Vaccine Conjugate Import and Export 6 Vaccine Conjugate Segment Market Analysis (by Type) 6.1 Global Vaccine Conjugate Production by Type 6.2 Global Vaccine Conjugate Revenue by Type 6.3 Vaccine Conjugate Price by Type 7 Vaccine Conjugate Segment Market Analysis (by Application) 7.1 Global Vaccine Conjugate Consumption by Application 7.2 Global Vaccine Conjugate Consumption Market Share by Application (2014-2019) 8 Vaccine Conjugate Major Manufacturers Analysis 8.1 Merck & Co., Inc. 8.1.1 Merck & Co., Inc. Vaccine Conjugate Production Sites and Area Served 8.1.2 Merck & Co., Inc. Product Introduction, Application and Specification 8.1.3 Merck & Co., Inc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 GlaxoSmithKline plc. 8.2.1 GlaxoSmithKline plc. Vaccine Conjugate Production Sites and Area Served 8.2.2 GlaxoSmithKline plc. Product Introduction, Application and Specification 8.2.3 GlaxoSmithKline plc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 SutroVax Inc. 8.3.1 SutroVax Inc. Vaccine Conjugate Production Sites and Area Served 8.3.2 SutroVax Inc. Product Introduction, Application and Specification 8.3.3 SutroVax Inc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Fablife. 8.4.1 Fablife. Vaccine Conjugate Production Sites and Area Served 8.4.2 Fablife. Product Introduction, Application and Specification 8.4.3 Fablife. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Pfizer 8.5.1 Pfizer Vaccine Conjugate Production Sites and Area Served 8.5.2 Pfizer Product Introduction, Application and Specification 8.5.3 Pfizer Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Sinovac Biotech Ltd. 8.6.1 Sinovac Biotech Ltd. Vaccine Conjugate Production Sites and Area Served 8.6.2 Sinovac Biotech Ltd. Product Introduction, Application and Specification 8.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Sanofi Pasteur SA. 8.7.1 Sanofi Pasteur SA. Vaccine Conjugate Production Sites and Area Served 8.7.2 Sanofi Pasteur SA. Product Introduction, Application and Specification 8.7.3 Sanofi Pasteur SA. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of Vaccine Conjugate Market 9.1 Global Vaccine Conjugate Market Trend Analysis 9.1.1 Global Vaccine Conjugate Market Size (Volume and Value) Forecast 2019-2025 9.2 Vaccine Conjugate Regional Market Trend 9.2.1 North America Vaccine Conjugate Forecast 2019-2025 9.2.2 Europe Vaccine Conjugate Forecast 2019-2025 9.2.3 China Vaccine Conjugate Forecast 2019-2025 9.2.4 Japan Vaccine Conjugate Forecast 2019-2025 9.2.5 Southeast Asia Vaccine Conjugate Forecast 2019-2025 9.2.6 India Vaccine Conjugate Forecast 2019-2025 9.3 Vaccine Conjugate Market Trend (Product Type) 9.4 Vaccine Conjugate Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Vaccine Conjugate Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Vaccine Conjugate Table Global Vaccine Conjugate Production (K MT) Growth Rate Comparison by Types (2014-2025) Figure Global Vaccine Conjugate Production Market Share by Types in 2018 Figure Monovalent Product Picture Figure Multivalent Product Picture Figure Others Product Picture Table Global Vaccine Conjugate Consumption (K MT) Comparison by Applications (2014-2025) Figure Global Vaccine Conjugate Consumption Market Share by Applications in 2018 Figure Influenza Figure Meningococcal Figure Pneumococcal Figure Others Figure Global Vaccine Conjugate Revenue (Million USD) (2014-2025) Figure Global Vaccine Conjugate Production (K MT) (2014-2025) Figure North America Vaccine Conjugate Market Size (Million USD) (2014-2025) Figure Europe Vaccine Conjugate Market Size (Million USD) (2014-2025) Figure China Vaccine Conjugate Market Size (Million USD) (2014-2025) Figure Japan Vaccine Conjugate Market Size (Million USD) (2014-2025) Figure Southeast Asia Vaccine Conjugate Market Size (Million USD) (2014-2025) Figure India Vaccine Conjugate Market Size (Million USD) (2014-2025) Table Vaccine Conjugate Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Vaccine Conjugate in 2018 Figure Manufacturing Process Analysis of Vaccine Conjugate Figure Industry Chain Structure of Vaccine Conjugate Table Capacity and Commercial Production Date of Key Manufacturers Table Global Vaccine Conjugate Manufacturing Plants Distribution Table Vaccine Conjugate Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Vaccine Conjugate Capacity (K MT) of Major Manufacturers (2014-2019) Table Vaccine Conjugate Production (K MT) of Major Manufacturers (2014-2019) Table Vaccine Conjugate Production Market Share of Major Manufacturers (2014-2019) Figure Vaccine Conjugate Production Share by Manufacturers in 2018 Table Vaccine Conjugate Revenue (Million US$) of Major Manufacturers (2014-2019) Table Vaccine Conjugate Revenue Market Share of Major Manufacturers (2014-2019) Figure Vaccine Conjugate Revenue Share by Manufacturers in 2018 Table Vaccine Conjugate Average Price (USD/MT) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Vaccine Conjugate Production by Regions 2014-2019 (K MT) Table Global Vaccine Conjugate Production Market Share by Regions 2014-2019 Figure Global Vaccine Conjugate Production Market Share by Regions in 2018 Table Global Vaccine Conjugate Revenue by Regions 2014-2019 (Million USD) Table Global Vaccine Conjugate Revenue Market Share by Regions 2014-2019 Figure Global Vaccine Conjugate Revenue Market Share by Regions in 2018 Table Global Vaccine Conjugate Consumption by Regions 2014-2019 (K MT) Table Global Vaccine Conjugate Consumption Market Share by Regions 2014-2019 Figure North America Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure North America Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table North America Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure Europe Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure Europe Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table Europe Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure China Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure China Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table China Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure Japan Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure Japan Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table Japan Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure Southeast Asia Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure Southeast Asia Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure India Vaccine Conjugate Production Growth Rate 2014-2019 (K MT) Figure India Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD) Table India Vaccine Conjugate Production, Consumption Import and Export (K MT) Figure Global Consumption Vaccine Conjugate Market Share by Application (2014-2019) Figure Global Value (Consumption) Vaccine Conjugate Market Share by Application (2014-2019) Table Merck & Co., Inc. Vaccine Conjugate Production Sites and Area Served Table Merck & Co., Inc. Vaccine Conjugate Product Introduction, Application and Specification Table Merck & Co., Inc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Merck & Co., Inc. Vaccine Conjugate Production Growth Rate (2014-2019) Table Merck & Co., Inc. Vaccine Conjugate Production Market Share (2014-2019) Figure Merck & Co., Inc. Vaccine Conjugate Revenue Market Share (2014-2019) Table Merck & Co., Inc. Vaccine Conjugate Main Business and Markets Served Table GlaxoSmithKline plc. Vaccine Conjugate Production Sites and Area Served Table GlaxoSmithKline plc. Vaccine Conjugate Product Introduction, Application and Specification Table GlaxoSmithKline plc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table GlaxoSmithKline plc. Vaccine Conjugate Production Growth Rate (2014-2019) Table GlaxoSmithKline plc. Vaccine Conjugate Production Market Share (2014-2019) Figure GlaxoSmithKline plc. Vaccine Conjugate Revenue Market Share (2014-2019) Table GlaxoSmithKline plc. Vaccine Conjugate Main Business and Markets Served Table SutroVax Inc. Vaccine Conjugate Production Sites and Area Served Table SutroVax Inc. Vaccine Conjugate Product Introduction, Application and Specification Table SutroVax Inc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table SutroVax Inc. Vaccine Conjugate Production Growth Rate (2014-2019) Table SutroVax Inc. Vaccine Conjugate Production Market Share (2014-2019) Figure SutroVax Inc. Vaccine Conjugate Revenue Market Share (2014-2019) Table SutroVax Inc. Vaccine Conjugate Main Business and Markets Served Table Fablife. Vaccine Conjugate Production Sites and Area Served Table Fablife. Vaccine Conjugate Product Introduction, Application and Specification Table Fablife. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Fablife. Vaccine Conjugate Production Growth Rate (2014-2019) Table Fablife. Vaccine Conjugate Production Market Share (2014-2019) Figure Fablife. Vaccine Conjugate Revenue Market Share (2014-2019) Table Fablife. Vaccine Conjugate Main Business and Markets Served Table Pfizer Vaccine Conjugate Production Sites and Area Served Table Pfizer Vaccine Conjugate Product Introduction, Application and Specification Table Pfizer Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Pfizer Vaccine Conjugate Production Growth Rate (2014-2019) Table Pfizer Vaccine Conjugate Production Market Share (2014-2019) Figure Pfizer Vaccine Conjugate Revenue Market Share (2014-2019) Table Pfizer Vaccine Conjugate Main Business and Markets Served Table Sinovac Biotech Ltd. Vaccine Conjugate Production Sites and Area Served Table Sinovac Biotech Ltd. Vaccine Conjugate Product Introduction, Application and Specification Table Sinovac Biotech Ltd. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Sinovac Biotech Ltd. Vaccine Conjugate Production Growth Rate (2014-2019) Table Sinovac Biotech Ltd. Vaccine Conjugate Production Market Share (2014-2019) Figure Sinovac Biotech Ltd. Vaccine Conjugate Revenue Market Share (2014-2019) Table Sinovac Biotech Ltd. Vaccine Conjugate Main Business and Markets Served Table Sanofi Pasteur SA. Vaccine Conjugate Production Sites and Area Served Table Sanofi Pasteur SA. Vaccine Conjugate Product Introduction, Application and Specification Table Sanofi Pasteur SA. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019) Table Sanofi Pasteur SA. Vaccine Conjugate Production Growth Rate (2014-2019) Table Sanofi Pasteur SA. Vaccine Conjugate Production Market Share (2014-2019) Figure Sanofi Pasteur SA. Vaccine Conjugate Revenue Market Share (2014-2019) Table Sanofi Pasteur SA. Vaccine Conjugate Main Business and Markets Served Figure Global Vaccine Conjugate Production (K MT) Growth Rate Forecast 2019-2025 Figure Global Vaccine Conjugate Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Vaccine Conjugate Sales Price (USD/MT) Forecast 2019-2025 Figure North America Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure North America Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure Europe Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure China Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure Japan Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure Southeast Asia Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT) Figure India Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K MT) of Vaccine Conjugate by Type (2019-2025) Table Global Consumption (K MT) of Vaccine Conjugate by Application (2019-2025) Table Vaccine Conjugate Distributors List Table Vaccine Conjugate Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck & Co., Inc. GlaxoSmithKline plc. SutroVax Inc. Fablife. Pfizer Sinovac Biotech Ltd. Sanofi Pasteur SA.